Canadian health officials confident in AstraZeneca vaccine despite blood-clotting issues in Europe

Canada did not receive the same batch of the vaccine

Canada’s top doc and the health minister have expressed confidence in the AstraZeneca vaccine despite concerns in several European countries over potential blood clots.

Some countries have suspended use of the vaccine, but authorities here say Canada hasn’t been supplied with the same batch of the vaccine so there’s no need to follow suit.

And the European Medicines Agency, which is looking into the issue, says 30 clots in more than five million patients are not out of step with the normal rate of blood clots in the general population.

AstraZeneca is the vaccine Ontario plans to vaccinate those aged 60-64 starting this weekend.

Canada received its first shipment of the vaccine last week – an initial 500,000 doses.